|
GLP1-RA (semaglutide) Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Early 1: 1
Top Sponsors
- University of Arizona1
Indications
- Liver Disease1
- Pancreatic Cancer1
- Liver Cancer1
- Colorectal Cancer1
- Hepatocellular Carcinoma1
Tucson, Arizona1 trial
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
University of Arizona Cancer Center
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.